Alcon Inc. balance sheet ALC

Annual Quarterly

As of Dec 31, 2025, Alcon Inc. had total assets of $31.6 billion and total liabilities of $9.5 billion. Total assets were up 4.0% from a year earlier. Stockholders' equity was $22.0 billion. It held $1.5 billion in cash and investments against $5.2 billion of total debt, net debt of $3.7 billion. The current ratio, current assets divided by current liabilities, was 2.12.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2010 Dec 31, 2010	FY 2009 Dec 31, 2009
Assets
Cash	1,527 -8.9%	1,676 +53.2%	1,094 +11.6%	980 -37.8%	1,575 +1.2%	1,557 +89.4%	822	2,525 -16.0%	3,007
Short-term investments	—	—	—	—	—	—	—	889 +85.6%	479
Long-term investments	—	—	—	—	—	—	—	398 +445.2%	73
Cash and investments	1,527 -8.9%	1,676 +53.2%	1,094 +11.6%	980 -37.8%	1,575 +1.2%	1,557 +89.4%	822	3,812 +7.1%	3,559
Receivables	—	—	—	—	—	—	—	1,483 +10.2%	1,346
Inventory	2,391 +5.4%	2,268 -2.3%	2,322 +10.1%	2,109 +11.1%	1,899 +15.5%	1,644 +9.2%	1,505	—	—
Total current assets	6,449 +2.2%	6,309 +11.7%	5,647 +8.7%	5,193 -3.6%	5,386 +8.0%	4,987 +17.7%	4,236	—	—
Property and equipment, net	4,774 +8.8%	4,389 +0.5%	4,369 +8.5%	4,025 +8.5%	3,711 +8.4%	3,425 +10.0%	3,113	—	—
Goodwill	9,256 +3.5%	8,946 +0.2%	8,926 +0.0%	8,926 +0.2%	8,905 +0.0%	8,905 +0.0%	8,905	833 +21.1%	688
Total assets	31,555 +4.0%	30,347 +2.5%	29,614 +1.5%	29,165 +4.2%	27,999 +1.4%	27,600 -0.2%	27,655	10,073 +16.0%	8,686
Liabilities and equity
Accounts payable	—	—	—	—	—	—	—	370 +15.3%	321
Total current liabilities	3,049 +33.8%	2,278 -5.0%	2,398 -12.4%	2,738 +10.8%	2,472 +9.5%	2,258 -1.8%	2,300	—	—
Total liabilities	9,520 +8.3%	8,794 -2.2%	8,990 -5.2%	9,488 +8.5%	8,743 -0.4%	8,778 +5.1%	8,352	—	—
Stockholders' equity	22,035 +2.2%	21,553 +4.5%	20,624 +4.8%	19,677 +2.2%	19,256 +2.3%	18,822 -2.5%	19,303	—	—
Debt
Debt due within a year	575 +447.6%	105 +66.7%	63 -41.1%	107 -6.1%	114 -32.5%	169 -35.2%	261	399 -39.8%	663
Long-term debt	4,162 -8.3%	4,538 -3.0%	4,676 +3.0%	4,541 +14.5%	3,966 +0.4%	3,949 +22.7%	3,218	—	—
Lease liabilities	509 +2.4%	497 +22.4%	406 -5.6%	430 +5.9%	406 +5.5%	385 +12.9%	341	—	—
Total debt	5,246 +2.1%	5,140 -0.1%	5,145 +1.3%	5,078 +13.2%	4,486 -0.4%	4,503 +17.9%	3,820	399 -39.8%	663
Net cash	-3,719 -7.4%	-3,464 +14.5%	-4,051 +1.1%	-4,098 -40.8%	-2,911 +1.2%	-2,946 +1.7%	-2,998	3,413 +17.9%	2,896
Ratios
Current ratio	2.12x	2.77x	2.35x	1.90x	2.18x	2.21x	1.84x	—	—
Debt to equity	0.24x	0.24x	0.25x	0.26x	0.23x	0.24x	0.20x	—	—
Return on equity	4.45%	4.72%	4.72%	1.70%	1.95%	-2.82%	-3.40%	—	—
Return on assets	3.11%	3.35%	3.29%	1.15%	1.34%	-1.92%	-2.37%	21.94%	23.11%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry: Ophthalmic Goods (SIC 3851)
Listed as: ALC (NYSE)
Fiscal year ends: December 31
Incorporated in: Switzerland
Headquarters: Fort Worth, TX
SEC filer status: Large accelerated filer
SEC CIK: 1167379

Other Ophthalmic Goods companies

All 8 Ophthalmic Goods companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.